DRTS logo

Alpha Tau Medical Stock Price

Symbol: NasdaqCM:DRTSMarket Cap: US$252.4mCategory: Healthcare

DRTS Share Price Performance

US$3.02
0.99 (48.77%)
US$3.02
0.99 (48.77%)
Price US$3.02

DRTS Community Narratives

There are no narratives available yet.

DRTS Community Fair Values

    Recent DRTS News & Updates

    No updates

    Alpha Tau Medical Ltd. Key Details

    US$0

    Revenue

    US$0

    Cost of Revenue

    US$0

    Gross Profit

    US$32.5m

    Other Expenses

    -US$32.5m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.38
    Gross Margin
    0%
    Net Profit Margin
    0%
    Debt/Equity Ratio
    9.7%

    Alpha Tau Medical Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About DRTS

    Founded
    n/a
    Employees
    125
    CEO
    Uzi Sofer
    WebsiteView website
    www.alphatau.com

    Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

    Israeli Market Performance

    • 7 Days: -1.7%
    • 3 Months: 18.6%
    • 1 Year: 67.6%
    • Year to Date: 27.4%
    Over the last 7 days, the market has dropped 1.7%, driven by losses in the Financials and Real Estate sectors of 1.8% and 2.9%, respectively. As for the longer term, the market has actually risen by 68% in the last year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading